Glycemic control for postoperative pediatric cardiac patients
Related Experiment Video
Updated: Jun 20, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Catherine M Preissig1, Mark R Rigby, Kevin O Maher
1Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. catherine.preissig@choa.org
Insights
Hyperglycemia is common in pediatric cardiac surgery patients, impacting outcomes. A specialized protocol effectively managed blood glucose levels without increasing hypoglycemia risks.
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Cardiovascular Surgery
Background:
- Hyperglycemia is a frequent complication in pediatric patients post-cardiac surgery.
- The clinical significance and effective management of hyperglycemia in this vulnerable population remain critical areas of investigation.
Purpose of the Study:
- To determine the prevalence of hyperglycemia in pediatric postoperative cardiac patients.
- To assess the impact of hyperglycemia on patient outcomes.
- To evaluate the efficacy and safety of a pediatric-specific glycemic control protocol for managing hyperglycemia.
Main Methods:
- Retrospective chart review of 100 pediatric postoperative cardiac intensive care unit (ICU) patients.
- Defined hyperglycemia as blood glucose (BG) > 7.7 mmol/l (140 mg/dl).
- Evaluated outcomes and analyzed BG control in 20 patients managed with a pediatric-specific insulin protocol.
Main Results:
- Hyperglycemia prevalence was 84% among studied patients.
- Hyperglycemic patients exhibited higher inotrope scores, prolonged hospital stays, increased mechanical ventilation days, and elevated mortality rates.
- The pediatric glycemic control protocol achieved 62% of BG values within the target range with <4% of values below 3.3 mmol/l (60 mg/dl), and no BG < 2.2 mmol/l (40 mg/dl).
Conclusions:
- Severe hyperglycemia is highly prevalent in pediatric postoperative cardiac patients and is associated with increased morbidity and mortality.
- A pediatric-specific glycemic control protocol can effectively manage hyperglycemia in these patients, with a low risk of hypoglycemia.
Abstract:
This study aimed to determine the prevalence of hyperglycemia among pediatric postoperative cardiac patients, its impact on outcomes, and whether hyperglycemia can be controlled effectively in this population. A retrospective chart review of 100 postoperative patients admitted to the authors' pediatric cardiac intensive care unit (ICU) was conducted. Patients were evaluated for incidence of hyperglycemia, defined as blood glucose (BG) level exceeding 7.7 mmol/l (140 mg/dl), and outcomes. The evaluation also included 20 different postoperative patients with a BG level exceeding 7.7 mmol/l (140 mg/dl) who received management with insulin via the authors' pediatric-specific glycemic control protocol. The BG control and hypoglycemic rates in this cohort were assessed. The prevalence of hyperglycemia was 84%. The hyperglycemic patients had higher inotrope scores, longer hospital stays, more mechanical ventilation days, and higher mortality rates than those without hyperglycemia. For the patients with hyperglycemia managed via the authors' pediatric-specific glycemic control protocol, 62% of all BG values were within the authors' goal range, and less than 4% of BG values were less than 3.3 mmol/l (60 mg/dl). No patient had a BG level lower than 2.2 mmol/l (40 mg/dl) during glycemic management. Severe hyperglycemia is prevalent among postoperative pediatric cardiac patients and correlates with morbidity and mortality. Hyperglycemia may be controlled effectively in these patients using a pediatric-specific glycemic control protocol without increasing the incidence of hypoglycemia.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Peripheral Artery Disease V: Postoperative Nursing Management
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...